FOXO Technologies Advances in AI-Driven Healthcare Growth
Company Announcements

FOXO Technologies Advances in AI-Driven Healthcare Growth

An update from FOXO Technologies ( (FOXO) ) is now available.

FOXO Technologies, a pioneer in epigenetic biomarker discovery, has had a transformative year in 2024, focusing on commercializing its technology and making strategic acquisitions to bolster growth in healthcare. The company’s recent acquisitions and patent for a machine learning model, which predicts health conditions using DNA data, position it for revenue expansion and innovation in AI-driven healthcare. FOXO is committed to meeting NYSE listing standards and enhancing shareholder value.

Learn more about FOXO stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskFOXO Technologies Issues New Stock and Negotiates Debt
TheFlyFoxo Technologies provides shareholder letter from Interim CEO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App